Giant Mammary HamartomaSymptoms, Doctors, Treatments, Advances & More
Giant Mammary Hamartoma Overview
Learn About Giant Mammary Hamartoma
MUSC Health Surgical Oncology At Bluffton Medical Campus
Rochelle Ringer is a General Surgeon practicing medicine in Bluffton, South Carolina. Dr. Ringer is rated as a Distinguished provider by MediFind in the treatment of Giant Mammary Hamartoma. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Paget Disease of the Breast, Galactocoele, and Lymphadenectomy. Dr. Ringer is currently accepting new patients.
Orlando Health Cancer Institute Breast Care Center - Ocoee
Jeffrey Smith is a General Surgeon and a Colorectal Surgeon practicing medicine in Ocoee, Florida. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Giant Mammary Hamartoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Intraductal Papilloma, Paget Disease of the Breast, Breast Cancer, Breast Lump, and Lymphadenectomy. Dr. Smith is board certified in American Board Of Surgery. Dr. Smith is currently accepting new patients.
Ascension Saint Agnes Breast Center
Kristen Fernandez is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Fernandez is rated as an Advanced provider by MediFind in the treatment of Giant Mammary Hamartoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy. Dr. Fernandez is board certified in The American Board Of Surgery - General Surgery. Dr. Fernandez is currently accepting new patients.
Summary: This is a phase 1b, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics of Sapu003 in combination with Exemestane in in patients with advanced mTOR-sensitive solid tumors (HR+/HER2-negative breast cancer, renal cell carcinoma \[RCC\], neuroendocrine tumors \[NETs\], tuberous sclerosis complex \[TSC\]-associated tumors, and hepatocellular carcinoma \[HCC\]).
Summary: The objective of this protocol is to develop an institution-wide liquid biopsy protocol that will establish a common process for collecting blood and corresponding archived tumor specimens for future research studies at the University Health Network's Princess Margaret Cancer Centre. Circulating cell-free nucleic acids (cfNA), including cell-free DNA (cfDNA) and cell-free RNA (cfRNA), are non-inva...


